Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation

Por Corbo, Vincenzo, Tortora, Giampaolo, Scarpa, Aldo
Publicado em 2012

Acquired hemophagocytic syndrome: comment to the case report

Por Ciccarese, Chiara, Massari, Francesco, Tortora, Giampaolo
Publicado no Future Sci OA (2015)

Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care

Por Martinelli, Erika, Morgillo, Floriana, Troiani, Teresa, Tortora, Giampaolo, Ciardiello, Fortunato
Publicado em 2007

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy

Por Tamburrino, Anna, Piro, Geny, Carbone, Carmine, Tortora, Giampaolo, Melisi, Davide
Publicado em 2013

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy

Por Pilotto, Sara, Gkountakos, Anastasios, Carbognin, Luisa, Scarpa, Aldo, Tortora, Giampaolo, Bria, Emilio
Publicado no Ann Transl Med (2017)

High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs

Por D’Angelo, Daniela, Mussnich, Paula, Rosa, Roberta, Bianco, Roberto, Tortora, Giampaolo, Fusco, Alfredo
Publicado no BMC Cancer (2014)

Toll-Like Receptor 9 Agonists for Cancer Therapy

Por Melisi, Davide, Frizziero, Melissa, Tamburrino, Anna, Zanotto, Marco, Carbone, Carmine, Piro, Geny, Tortora, Giampaolo
Publicado no Biomedicines (2014)

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

Por Modena, Alessandra, Ciccarese, Chiara, Iacovelli, Roberto, Brunelli, Matteo, Montironi, Rodolfo, Fiorentino, Michelangelo, Tortora, Giampaolo, Massari, Francesco
Publicado no Oncol Rev (2016)

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research

Por Bonomi, Maria, Pilotto, Sara, Milella, Michele, Massari, Francesco, Cingarlini, Sara, Brunelli, Matteo, Chilosi, Marco, Tortora, Giampaolo, Bria, Emilio
Publicado em 2011

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors

Por Santoni, Matteo, Bracarda, Sergio, Nabissi, Massimo, Massari, Francesco, Conti, Alessandro, Bria, Emilio, Tortora, Giampaolo, Santoni, Giorgio, Cascinu, Stefano
Publicado em 2014

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

Por Pilotto, Sara, Carbognin, Luisa, Karachaliou, Niki, Garassino, Marina, Cuppone, Federica, Petraglia, Sandra, Rosell, Rafael, Tortora, Giampaolo, Bria, Emilio
Publicado no Transl Lung Cancer Res (2015)

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Ne...

Por Carbognin, Luisa, Pilotto, Sara, Nortilli, Rolando, Brunelli, Matteo, Nottegar, Alessia, Sperduti, Isabella, Giannarelli, Diana, Bria, Emilio, Tortora, Giampaolo
Publicado no Oncologist (2016)

Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A

Por Tortora, Giampaolo, Caputo, Rosa, Damiano, Vincenzo, Bianco, Roberto, Pepe, Stefano, Bianco, A. Raffaele, Jiang, Zhiwei, Agrawal, Sudhir, Ciardiello, Fortunato
Publicado em 1997

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Por Melisi, Davide, Ishiyama, Satoshi, Sclabas, Guido M., Fleming, Jason B., Xia, Qianghua, Tortora, Giampaolo, Abbruzzese, James L., Chiao, Paul J.
Publicado em 2008

Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials

Por CARLOMAGNO, CHIARA, DANIELE, GENNARO, BIANCO, ROBERTO, MARCIANO, ROBERTA, DAMIANO, VINCENZO, MATANO, ELIDE, NAPPI, LUCIA, PEPE, STEFANO, DE PLACIDO, SABINO, TORTORA, GIAMPAOLO
Publicado em 2011

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity

Por Pilotto, Sara, Molina-Vila, Miguel Angel, Karachaliou, Niki, Carbognin, Luisa, Viteri, Santiago, González-Cao, Maria, Bria, Emilio, Tortora, Giampaolo, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2015)

Overcoming resistance to molecularly targeted anticancer therapies: rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies

Por Tortora, Giampaolo, Bianco, Roberto, Daniele, Gennaro, Ciardiello, Fortunato, McCubrey, James A, Ricciardi, Maria Rosaria, Ciuffreda, Ludovica, Cognetti, Francesco, Tafuri, Agostino, Milella, Michele
Publicado em 2007

Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

Por Vaccaro, Vanja, Sperduti, Isabella, Vari, Sabrina, Bria, Emilio, Melisi, Davide, Garufi, Carlo, Nuzzo, Carmen, Scarpa, Aldo, Tortora, Giampaolo, Cognetti, Francesco, Reni, Michele, Milella, Michele
Publicado no World J Gastroenterol (2015)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder

Por Massari, Francesco, Bria, Emilio, Ciccarese, Chiara, Munari, Enrico, Modena, Alessandra, Zambonin, Valentina, Sperduti, Isabella, Artibani, Walter, Cheng, Liang, Martignoni, Guido, Tortora, Giampaolo, Brunelli, Matteo
Publicado no PLoS One (2015)

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis

Por Carbone, Carmine, Piro, Geny, Fassan, Matteo, Tamburrino, Anna, Mina, Maria Mihaela, Zanotto, Marco, Chiao, Paul J, Bassi, Claudio, Scarpa, Aldo, Tortora, Giampaolo, Melisi, Davide
Publicado no Oncotarget (2014)